Advertisement
UK markets close in 5 hours 30 minutes

  • FTSE 100

    8,352.50
    +38.83 (+0.47%)
     

  • FTSE 250

    20,422.39
    +9.31 (+0.05%)
     

  • AIM

    777.48
    +1.06 (+0.14%)
     

  • GBP/EUR

    1.1615
    -0.0009 (-0.08%)
     

  • GBP/USD

    1.2493
    -0.0016 (-0.13%)
     

  • Bitcoin GBP

    49,883.39
    -1,442.89 (-2.81%)
     

  • CMC Crypto 200

    1,286.43
    -8.24 (-0.64%)
     

  • S&P 500

    5,187.70
    +6.96 (+0.13%)
     

  • DOW

    38,884.26
    +31.99 (+0.08%)
     

  • CRUDE OIL

    77.23
    -1.15 (-1.47%)
     

  • GOLD FUTURES

    2,318.10
    -6.10 (-0.26%)
     

  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     

  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     

  • DAX

    18,531.25
    +101.20 (+0.55%)
     

  • CAC 40

    8,154.46
    +78.78 (+0.98%)
     
Money:

How to make a tax-free income

Tips for making money that won't be taxed

Is DexCom (DXCM) Stock Outpacing Its Medical Peers This Year?

Zacks Equity Research
·2-min read

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is DexCom (DXCM) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.

DexCom is a member of the Medical sector. This group includes 902 individual stocks and currently holds a Zacks Sector Rank of #2. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. DXCM is currently sporting a Zacks Rank of #2 (Buy).

Over the past three months, the Zacks Consensus Estimate for DXCM's full-year earnings has moved 2.18% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

ADVERTISEMENT

Based on the latest available data, DXCM has gained about 9.82% so far this year. At the same time, Medical stocks have gained an average of 2.29%. This means that DexCom is outperforming the sector as a whole this year.

Looking more specifically, DXCM belongs to the Medical - Instruments industry, which includes 96 individual stocks and currently sits at #105 in the Zacks Industry Rank. Stocks in this group have gained about 1.32% so far this year, so DXCM is performing better this group in terms of year-to-date returns.

Investors with an interest in Medical stocks should continue to track DXCM. The stock will be looking to continue its solid performance.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Avis Budget Group, Inc. (CAR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research